ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Oct 30, 2015
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Exercise/Conversion
Common Stock
2015-10-28$2.69/sh+5,359$14,416→ 19,921 total - Exercise/Conversion
Stock Option (right to buy)
2015-10-28−5,359→ 0 totalExercise: $2.69From: 2008-10-28Exp: 2015-10-28→ Common Stock (5,359 underlying)